Cargando…
Identification of a Novel Immune-Related CpG Methylation Signature to Predict Prognosis in Stage II/III Colorectal Cancer
With the increasing incidence of colorectal cancer (CRC) and continued difficulty in treating it using immunotherapy, there is an urgent need to identify an effective immune-related biomarker associated with the survival and prognosis of patients with this disease. DNA methylation plays an essential...
Autores principales: | Chen, Feng, Pei, Lijuan, Liu, Siyao, Lin, Yan, Han, Xinyin, Meng, Erhong, Wang, Xintong, Hong, Shuai, Wang, Dongliang, Liu, Feide, Fei, Yang, Wang, Guangda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8273301/ https://www.ncbi.nlm.nih.gov/pubmed/34262597 http://dx.doi.org/10.3389/fgene.2021.684349 |
Ejemplares similares
-
Regulatory pattern of abnormal promoter CpG island methylation in the glioblastoma multiforme classification
por: Wang, Rendong, et al.
Publicado: (2022) -
A Qualitative Transcriptional Signature for Predicting CpG Island Methylator Phenotype Status of the Right-Sided Colon Cancer
por: You, Tianyi, et al.
Publicado: (2020) -
Screening the genome for HCC-specific CpG methylation signatures as biomarkers for diagnosis and prognosis evaluation
por: Zhang, Rui-kun, et al.
Publicado: (2021) -
An Eight-CpG-based Methylation Classifier for Preoperative Discriminating Early and Advanced-Late Stage of Colorectal Cancer
por: Hu, Ji, et al.
Publicado: (2021) -
Site-specific CpG methylation in the CCAAT/enhancer binding protein delta (CEBPδ) CpG island in breast cancer is associated with metastatic relapse
por: Palmieri, C, et al.
Publicado: (2012)